BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23935377)

  • 21. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with type 2 diabetes mellitus.
    Grabež M; Škrbić R; Stojiljković MP; Vučić V; Rudić Grujić V; Jakovljević V; Djuric DM; Suručić R; Šavikin K; Bigović D; Vasiljević N
    Rev Cardiovasc Med; 2022 Feb; 23(2):57. PubMed ID: 35229548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial.
    Varnasseri M; Siahpoosh A; Hoseinynejad K; Amini F; Karamian M; Yad MJY; Cheraghian B; Khosravi AD
    Complement Ther Med; 2022 May; 65():102808. PubMed ID: 35093510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidant activity of active tannoid principles of Emblica officinalis (amla).
    Bhattacharya A; Chatterjee A; Ghosal S; Bhattacharya SK
    Indian J Exp Biol; 1999 Jul; 37(7):676-80. PubMed ID: 10522157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amla (Emblica officinalis Gaertn.) attenuates age-related renal dysfunction by oxidative stress.
    Yokozawa T; Kim HY; Kim HJ; Tanaka T; Sugino H; Okubo T; Chu DC; Juneja LR
    J Agric Food Chem; 2007 Sep; 55(19):7744-52. PubMed ID: 17715896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review on the cardiovascular pharmacology of
    Hashem-Dabaghian F; Ziaee M; Ghaffari S; Nabati F; Kianbakht S
    J Cardiovasc Thorac Res; 2018; 10(3):118-128. PubMed ID: 30386531
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of Emblica officinalis aqueous extract on growth and antioxidant defense system of human hepatoma cell line (HepG2).
    Shivananjappa MM; Joshi MK
    Pharm Biol; 2012 Apr; 50(4):497-505. PubMed ID: 22133060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
    Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
    Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amla (Emblica officinalis) improves hepatic and renal oxidative stress and the inflammatory response in hypothyroid female wistar rats fed with a high-fat diet.
    Muthu PR; Bobby Z; Sankar P; Vickneshwaran V; Jacob SE
    J Basic Clin Physiol Pharmacol; 2018 Mar; 29(2):175-184. PubMed ID: 29267168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in biotechnology of
    Gantait S; Mahanta M; Bera S; Verma SK
    3 Biotech; 2021 Feb; 11(2):62. PubMed ID: 33489680
    [No Abstract]   [Full Text] [Related]  

  • 31. Standardized Emblica officinalis fruit extract inhibited the activities of α-amylase, α-glucosidase, and dipeptidyl peptidase-4 and displayed antioxidant potential.
    Majeed M; Majeed S; Mundkur L; Nagabhushanam K; Arumugam S; Beede K; Ali F
    J Sci Food Agric; 2020 Jan; 100(2):509-516. PubMed ID: 31487036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicological Evaluation of Emblica officinalis Fruit Extract and its Anti-inflammatory and Free Radical Scavenging Properties.
    Middha SK; Goyal AK; Lokesh P; Yardi V; Mojamdar L; Keni DS; Babu D; Usha T
    Pharmacogn Mag; 2015 Oct; 11(Suppl 3):S427-33. PubMed ID: 26929577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of Synbiotic Supplementation on Carotid Intima-Media Thickness, Biomarkers of Inflammation, and Oxidative Stress in People with Overweight, Diabetes, and Coronary Heart Disease: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Farrokhian A; Raygan F; Soltani A; Tajabadi-Ebrahimi M; Sharifi Esfahani M; Karami AA; Asemi Z
    Probiotics Antimicrob Proteins; 2019 Mar; 11(1):133-142. PubMed ID: 29079990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients.
    Chen TS; Liou SY; Chang YL
    Am J Chin Med; 2009; 37(1):19-25. PubMed ID: 19222108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in endothelial dysfunction in patients with systemic lupus erythematosus with N-acetylcysteine and atorvastatin.
    Kudaravalli J
    Indian J Pharmacol; 2011 May; 43(3):311-5. PubMed ID: 21713097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiproliferative effect of silver nanoparticles synthesized using amla on Hep2 cell line.
    Rosarin FS; Arulmozhi V; Nagarajan S; Mirunalini S
    Asian Pac J Trop Med; 2013 Jan; 6(1):1-10. PubMed ID: 23317879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPLC fingerprint analysis of Phyllanthus emblica ethanol extract and their antioxidant and anti-inflammatory properties.
    Li W; Zhang X; Chen R; Li Y; Miao J; Liu G; Lan Y; Chen Y; Cao Y
    J Ethnopharmacol; 2020 May; 254():112740. PubMed ID: 32151757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
    Castaño G; Fernández L; Mas R; Illnait J; Mesa M; Fernández JC
    Clin Drug Investig; 2003; 23(10):639-50. PubMed ID: 17535079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial.
    van Venrooij FV; van de Ree MA; Bots ML; Stolk RP; Huisman MV; Banga JD;
    Diabetes Care; 2002 Jul; 25(7):1211-6. PubMed ID: 12087021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.